ABSTRACT

Objective:

This study was conducted to evaluate quality of life, functional status and pain in elderly patients with rheumatoid arthritis (RA).

Methods:

The sample of this study consisted of 229 outpatients followed up in the rheumatology department of a hospital with a diagnosis of RA and those over 65 years old who were treated in the internal medicine clinic of the same hospital. Research data were collected using a Personal Introduction Form, the Disease Activity score 28 (DAS-28), the Numerical Pain Assessment Scale, the Health Assessment Questionnaire (HAQ) and the SF-36 Quality of Life scale.

Results:

The physical conditions of the non-RA elderly individuals were statistically worse compared to those with RA (p=0.01). There was a significant negative correlation between patient age and visual analog score, physical function, physical role limitations, emotional role limitations and social functionality subscale scores, and a significant positive correlation between age and HAQ scores (p<0.05).

Conclusion:

In the study, elderly patients with RA had fewer physical limitations in daily activities and their severity of pain was not different than that of adult patients with RA. The physical and social functionality of the elderly who had received treatment due to a chronic disease other than RA had lower physical and social functionality, but their quality of life was better.

Keywords:

Elderly patients, functional status, quality of life, rheumatoid arthritis

Introduction

Rheumatoid arthritis (RA) is a frequently seen systemic autoimmune disease of the musculoskeletal system, primarily affecting the synovial joint leading to progressive disability (1). The disease is mostly seen between the ages of 20-50, and occasionally in older people (2). Approximately 30% of RA cases occur in old age and that rate is increasing every day worldwide (3). The elderly RA population consists of both individuals who develop RA at an advanced age and patients diagnosed as having RA early in life (4). The occurrence of the disease at age 60 and above is defined as late-onset or elderly-onset RA (5). Old age related physiological changes and RA that occurs in advanced ages cause a decrease in functional capacity (6).In studies, patients with late-onset RA were reported to have more prominent and acute symptoms and higher disease activity than patients with early-onset RA (7,8). Some studies, on the other hand, have reported that the response to anti tumor necrosis factor-alpha (TNF- α) drugs used in the treatment of RA varies according to age groups, and that the response is better in young people (9). Though, the reason for this difference between age groups in terms of disease activity cannot be fully explained.

Chronic inflammation and pain often lead to a decrease in physical activity and functional disabilities in patients with RA (10) and a significant reduction in the quality of life (11,12). Low quality of life is associated with high disease activity and functional disability (13,14). Since functional disability is associated with disease activity and radiographic joint damage, functionality is frequently used as an outcome to evaluate the effect of RA over time (15). In a study conducted with an Asian population, it was found that patients with late-onset RA had a worse functional status due to comorbidities than patients with early-onset RA. On the other hand, despite their poor physical functionality, patients with late-onset RA were reported to cope better emotionally and mentally than patients with early-onset RA (16). In another study comparing disease activity and the quality of life of patients with RA both under and over 60, it was determined that the physical health and physical functions of elderly patients with RA were worse and that their quality of life was more negatively affected (17).

Individuals have difficulty in fulfilling their daily activities due to physical dependence and functional regression with old age. With aging, the quality of life deteriorates due to disease-related complications, comorbidities, social or economic problems, and changes in daily life activities (18,19). In another study examining the relationship between age and quality of life in individuals with RA, it was reported that elderly patients with RA, similar to the general population, had lower quality of life scale scores in terms of physical activity than younger patients with RA (20). Health professionals should be aware of disease-related inflammatory changes and old age-related physiological changes while ensuring the follow-up and care of elderly patients with RA. In this study, the functionality and quality of life of elderly patients with RA was evaluated by comparing with younger patients with RA and elderly non-RA individuals.

Methods

Study Design

This descriptive study aims to evaluate quality of life, functional status and pain in elderly patients with RA.

Research Place

Research was carried out at the rheumatology outpatient clinic and internal diseases clinic of university hospital after obtaining permission from the ethics committee and the institution.

Sample

The sample of the study consisted of patients who were over 18, treated and monitored due to a diagnosis of RA in the outpatient and internal clinic of the rheumatology department, and patients aged 65 being treated in the internal diseases clinic of university hospital. All included were literate and agreed to participate in the study (Figure 1).

According to an age classification of the World Health Organization (www.healthindicators.org), RA patients between 18-65 formed the adult group, patients over 65 constituted the elderly group and individuals over 65 who had been treated for any other health issue in the internal medicine clinic formed the non-RA elderly group. A power analysis was used to determine the size of the research sample. In calculating the sample, the results of the study conducted by Koçyigit et al. (21) were used as reference and the size of the sample was determined as 225 units, 75 units in each group, with a power of 80%, type I error of 5% and medium effect size (ES =0.3). The study was completed with a total of 229 patients (21).

Exclusion criteria of the research

• Patients with a variable level of consciousness (changes in consciousness such as confusion, stupor, dementia),

• Patients with a known psychiatric disorder,

• Patients with severe hearing or visual impairment,

• Patients who did not agree to participate in the study were not included.

Data collection method and data collection tools

In the study, patients who met the inclusion criteria were informed by a researcher and written consent was obtained. A Personal Introduction Form developed by researchers according to available literature, the Disease Activity Score 28 (DAS-28), the Numerical Pain Assessment Scale, the Health Assessment Questionnaire (HAQ) and the Short Form of Survey-36 (SF-36) Quality of Life Scale were implemented to patients using via face-to-face interview.

Personal introduction form: this form was developed by researchers according to the literature (22,23) and consisted of 18 questions on socio-demographic characteristics, disease and treatment.

Disease activity score 28 (DAS-28): This is a score routinely used during RA exams to evaluate disease activity in which 28 joints are assessed for tenderness and swelling. A value of 2.6 and below is evaluated as remission, between 2.6-3.2 is considered low disease activity, between 3.2-5.1 is moderate activity and a value above 5.1 is high disease activity (24).In this study, the level of disease activity was determined using this score during physical examination.

Numerical pain assessment scale: This scale, which aimed to assess the severity of patient pain, was used to explain the pain in numbers. On the scale, a score of 0 indicates no pain and 10 confers excruciating pain (25).

Health assessment questionnaire (HAQ): The HAQ was developed by Fries et al. in 1980 to evaluate the physical limitations of patients with RA. It gauges activities of daily living consisting of 20 items in 8 sections. Each item is scored between 0-3 (0: no difficulty at all, 1: some difficulty, 2: great difficulty, 3: cannot do it at all). The scale was adapted to our society and Cronbach’s alpha coefficient was 0.97 (26).

SF-36 quality of life scale: SF 36 is one of the most common metrics used to measure quality of life. It was developed by Ware et al. in 1992. Turkish validity and reliability study of this scale was performed by Koçyigit et al. (21) The short form of the scale consists of 36 items and 8 subscales, which are: physical function, social function, mental health, physical role limitations, emotional role limitations, vitality/energy, pain, and general health perception. Subscales evaluate health between 0 and 100, with a score of 0 indicating poor health and a score of 100 showing good health. Koçyigit et al. (21) found that Cronbach’s alpha values of the subscales were between 0.73-0.76.

Statistical Analysis

A statistics package program was used in the analysis of data obtained in the study. Shapiro-Wilk test was used to examine the conformity of quantitative variables to normal distribution and it was determined that the quantitative variables were not normally distributed. The summary values of the non-normally distributed quantitative variables were shown as the median (Q1-Q3). Intergroup distributions of quantitative variables with no normal distribution were compared with Kruskal-Wallis and Mann-Whitney U tests. Qualitative variables were expressed with frequency and percentage, and the relationship between qualitative variables was evaluated with the pearson chi-square test. Spearmen’s test was used to evaluate the correlation between variables. Results with a p-value of <0.05 were considered significant.

Ethical Approval

Ethics committee approval dated 15.05.2018 with number 17 was obtained from the non-interventional ethics committee of a university and written consent from the relevant institution. The researchers informed all patients about the study and obtained written consent from them that they wanted to participate in the study. The patients were told that their participation in the study was entirely at their own discretion and that they could refuse to participate or withdraw from the study at any time. When they wanted to withdraw from the study, they were informed that the treatment planned by their physician would not be interrupted or changed.

Results

Patients’ Sociodemographic and Medical Characteristics

When the sociodemographic and medical characteristics of the patients participating in the study were compared, there were statistically significant differences in all three groups in terms of gender, education level, profession, receiving care from family members, employment status, social security, smoking, hypertension, diabetes mellitus, chronic kidney disease, and coronary artery disease (p<0.05) (Tables 1, 2). More than half of the patients in all three groups were female (51.3%) and primary school graduates (56.8%), the majority were married (76.9%), 90% were unemployed (Table 1). The rate of smoking was higher in adult patients with RA (23.4%). The rates of hypertension (53.9%), diabetes mellitus (53.9%), chronic kidney disease (18.4%) and coronary artery disease (23.7%) were higher in elderly non-RA individuals (Table 2). The median ages of adult patients withRA, elderly patients with RA and elderly non-RA individuals were 56 (51-62), 70 (66-73.5) and 71 (66.5-75.5), respectively.

The median durations of disease in adult and elderly patients with RA were 9 (5-15) and 14 (5-19.5) years, respectively. While adult patients with RA had been receiving treatment for an average of 8 years, elderly patients with RA had been receiving treatment for an average of 12 years. The duration of disease and the treatments used were statistically different (p<0.05) but disease activity scores (DAS-28 score) and duration of treatment were similar (p>0.05) among the groups. Patients with RA in both groups mostly received antirheumatic therapy (47.6%) and biologic agents (22.2%) (Table 2).

Comparison of Patients’ VAS, HAQ, and SF-36 Quality of Life Scale Scores

The severity of pain of the patients with RA in our study was moderate according to VAS scores, and the severity of pain of elderly non-RA individuals was statistically lower (p<0.001). The HAQ score of elderly non-RA individuals was significantly higher than that of the patients with RA. According to this result, it was determined that the physical condition of the elderly non-RA individuals was statistically worse than the patients with RA (p=0.01). It was determined that, there was a significant difference between the groups in terms of the SF-36 Quality of Life scale scores for physical role limitations, physical function, social functionality and mental health subscale (p<0.05). Adult patients with RA had significantly higher physical functionality and physical role limitation scores than elderly patients with RA and non-RA patients. The social functionality score of elderly non-RA individuals was lower than that of adult and elderly patients with RA, and their mental health score was also lower than that of elderly patients with RA (p=0.006) (Table 3).

Correlation between Patients’ Sociodemographic, Disease and Treatment Characteristics and VAS, HAQ, and SF-36 Quality of Life Scale Scores

In our study, there was a weak, negative significant correlation between age and VAS score (r=-0.160, p=0.015), physical function (r=-0.301, p<0.001), physical role limitations (r=-0.184, p:0.005), emotional role limitations (r=-0.151, p=0.023) and social functionality (r=-0.168, p:0.011) subscale scores. There was a weak positive significant correlation between the patient’s age and HAQ score (r=0.199, p=0.002). There was a weak, positive highly significant correlation between the patient’s VAS score and HAQ score (r=-0.288, p<0.001), a weak negative significant correlation between VAS score and physical role limitations (r=-0.177, p=0.007), vitality (r=-0.177, p=0.007), social functionality (r=-0.188, p=0.004) and general health perception (r=-0.288, p<0.001) subscale scores. A moderate, very significant negative correlation was found between VAS score and pain subscale score (r:-0.485, p<0.001). There was a strong negative correlation between patient’s HAQ score and physical function subscale scores (r=-0.721, p<0.001), a moderate, highly significant negative correlation between HAQ score and physical role limitations (r=-0.457, p<0.001), vitality (r=-0.434, p<0.001), social functionality (r=-0.597, p<0.001), pain (r=-0.588, p<0.001) and general health perception (r=-0.463, p<0.001) subscale scores. Also, a weak very significant negative correlation between patient’s HAQ score and emotional role limitations (r=-0.339, p<0.001) and mental health (r=-0.253, p<0.001) subscale scores was determined (Table 4).

The duration of disease in patients with RA was weakly positively correlated with HAQ score and negatively correlated with physical function, physical role limitations and emotional role limitations subscale scores. The duration of treatment in patients with RA, on the other hand, was weakly positively correlated with HAQ score, but weakly negatively correlated with physical function and emotional role limitations subscale scores. There was a highly significant positive correlation between the DAS-28 score and VAS score of the patients with RA (r=0.708, p<0.001), a moderate positive significant correlation between DAS-28 and HAQ scores, and a weak negative significant correlation between the DAS-28 score and physical function (r=-0.193, p=0.017), physical role limitations (r=-0.457, p<0.001), social functionality (r=-0.233, p=0.004) and pain (r=-0.395, p<0.001) scores (Table 5).

Discussion

Within the scope of the study, pain, quality of life and functional status of elderly patients with RA were all evaluated by comparing with adult patients with RA and elderly non-RA patients. Results showed that the severity of pain was lower in elderly non-RA patients than in adult and elderly patients with RA, but was not different between adult and elderly patients with RA. The fact that the severity of pain scores of patients in both RA groups were higher than the elderly individuals with chronic diseases other than RA was due to the primary characteristic of RA, pain. As a matter of fact, genetic predisposition, comorbidities such as osteoarthritis, fibromyalgia, depression, acute inflammatory exacerbations, chronic inflammation, structural damage, changes in the transmission and perception of pain and pain itself are observed in patients with RA due to the effect of coping mechanisms (27). In our study, pain scores increased as the disease activity of RA increased (r=0,708, p<0,001). Strand et al. (28) stated that patients with RA described any day they spend pain-free as a “good day”, emphasizing that this situation was rare. Lisitsyna et al. (29) stressed that the severity of pain in patients with RA was high in those using conventional disease-modifying antirheumatic drugs (DMARDs), and Simon et al. (30) stated that treatments that inhibited the JAK/STAT pathway provided successful pain management. In our study, the treatments of adult and elderly patients with RA were statistically different and antirheumatic treatment was more common in the adult group, whereas steroid, biologic agents and non-steroidal anti-inflammatory drugs were more common in the elderly RA group.

According to the results of the HAQ, the group with less physical limitations in activities of daily living was elderly patients with RA, whereas limitations were more common in elderly non-RA individuals. In our study, it was thought that this was caused by a high number of chronic diseases in elderly non-RA individuals and poor health conditions which required hospitalization and treatment in the internal diseases clinic. As seen in Table 2, although the number of patients with chronic kidney disease, coronary artery disease, diabetes and hypertension were higher in both elderly groups compared to the adult RA group, these diseases were more common in the elderly non-RA group (p<0.05). One of the reasons for the low functionality in elderly individuals without RA may be that geriatric syndromes are very common in the elderly in general. Multiple comorbidities are difficult to manage in elderly patients and this increases susceptibility to geriatric syndromes (31,32) and negatively affects functional capacity (33).

In our study, although the mean RA disease activity scores in both RA groups were similar, the disease activity was moderate in adult patients with RA and mild in elderly patients with RA according to the criteria used to evaluate the DAS-28 scores. In addition, although the number of chronic diseases was higher in the elderly RA group, the level of physical limitations in activities of daily living was higher in adult patients with RA than in the elderly RA patients. The adult RA group was more active in daily life and participated in social and business life more than the elderly RA group. As a matter of fact, in our study, it was seen that adult patients with RA were more active workers than elderly patients with RA, and their functionality worsened as disease activity score increased. It was thought that both this situation and moderate disease activity level may have contributed to the perception that adult patients with RA were more limited in daily activities compared to elderly patients with RA. Moreover, it was predicted in the study that sociodemographic factors might also affect the level of limitation in activities of daily living because the number of patients in the adult RA group who had been giving care to their family members was higher than in the elderly RA group. Independent of the disease, females are generally expected to organize housework and take more responsibility in the care of children and the elderly as well as maintain an active work life. Therefore, expecting fulfilling these duties and responsibilities may lead to the perception of more restriction in activities of daily living due to the effect of rheumatoid arthritis.

When the perceptions of patients regarding quality of life were evaluated, the median scores of the adult patient group on quality of life subscales were higher compared to the other two elderly patient groups. It was found that quality of life decreased as age increased. An increase in the number of chronic diseases in the elderly (34), use of multiple medications, decreased cognitive functions (4), emotional problems (4,35,36), physical inactivity (37), and withdrawal from social life (38) are all factors reducing the quality of life of the elderly group. In our study, similar to the literature, the number of chronic diseases and the number of medications used due to chronic diseases were high and the number of active workers was low in the elderly population.

In the study, it was observed that the level of physical function, one of the subscales of quality of life, in the elderly non-RA patient group was lower than in both RA groups. It was thought that this difference observed especially in the two elderly groups of which mean ages were very close to each other, was due to the fact that the elderly non-RA group had more chronic kidney disease, diabetes, coronary artery disease and that the general condition of these patients was poor and required inpatient treatment, rather than old-age related physiological and psychosocial changes. While susceptibility to geriatric syndromes increases due to the presence of multiple comorbidities, functional capacity decreases (31,33). Geriatric syndromes have been shown to be associated with lower quality of life in several different elderly populations (32,39). In the study, physical role limitations, social functionality, and mental health levels of the elderly non-RA patients were statistically significantly lower than adult patients with RA. Moreover, the social functionality level was better in the elderly patients with RA than in the elderly non-RA patients but their pain, general health status, vitality, and emotional role limitation levels were not statistically different.

As disease activity increases in RA, functional limitation increases. For this reason, it is important to stratify adult and elderly RA groups as remission and low, moderate or high disease activity according to the scores obtained from DAS-28 in order to evaluate the physiological changes and comorbid conditions brought by old age and the effect of RA on functional status. The limitation of our research was that this stratification could not be made.

Study Limitations

The descriptive type of the research prevents the generalization of the results to the population. Research results are based on patients’ self-report, which may cause bias in elderly patients’ recall of their health status.

Implications

Although the disease activity of elderly patients with RA is lower than adults, these patients have more chronic diseases and have a lower quality of life. For this reason, it is recommended that healthcare professionals evaluate chronic conditions in patients and their quality of life as well as disease activity in elderly patients with RA, and offer individualized health care.

Conclusion

In the study, elderly patients with RA showed a mild disease activity and more chronic diseases than adult patients with RA. Compared to adult patients with RA, elderly patients with RA had fewer physical limitations in activities of daily living and their severity of pain was not different. On the other hand, the physical and social functionality of elderly patients who had received treatment at the hospital due to a chronic disease other than RA were lower, and the quality of life of adults was better compared to the elderly. When these results are considered, it is recommended to consider disease activity, comorbid conditions, physical and psycho-social capacities rather than age in planning the care of patients.

Ethics

Ethics Committee Approval: Eskişehir Osmangazi University, Non-invasive Clinical Research Ethics Committee (date: 15.05.2018/no: 17).

Informed Consent: In the study, patients who met the inclusion criteria were informed by a researcher and written consent was obtained.

Peer-review: Externally peer reviewed.

Authorship Contributions

Concept: F.U., N.Ş.Y.B., A.Ö., Design: F.U., N.Ş.Y.B., A.Ö., Data Collection or Processing: F.U., N.Ş.Y.B., A.Ö., Analysis or Interpretation: F.U., N.Ş.Y.B., A.Ö., Literature Search: F.U., N.Ş.Y.B., A.Ö., Writing: F.U., N.Ş.Y.B., A.Ö.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study received no financial support.

References

Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016;388:2023-38.

Wasserman AM. Diagnosis and management of rheumatoid arthritis. Am Fam Physician 2011;84:1245-52.

Yathish GC, Balakrishnan C, Gurmeet M, Parikshit S. Immunomodulators in managing geriatric rheumatoid arthritis. Internet Journal of Rheumatology and Clinical Immunology 2015;3:1-5.

Serhal L, Lwin MN, Holroyd C, Edwards CJ. Rheumatoid arthritis in the elderly: Characteristics and treatment considerations. Autoimmun Rev 2020;19:102528.

Ergin ES, Kibar S. Arthritis at advanced age: rheumatoid arthritis and differential diagnosis. Turk J Phys Med Rehab 2013;59:242-9.

Omma A, Çelik S, Bes C, Pehlivan Ö, Sandıkçı SC, Öner SY, et al. Short report: correlates of functional disability with disease activity in elderly patients with rheumatoid arthritis. Psychol Health Med 2018;23:668-73.

Boeters DM, Mangnus L, Ajeganova S, Lindqvist E, Svensson B, Toes REM, et al. The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical. Arthritis Res Ther 2017;19:115.

Pawłowska J, Smoleńska Z, Daca A, Witkowski JM, Bryl E. Older age of rheumatoid arthritis onset is associated with higher activation status of peripheral blood CD4(+) T cells and disease activity. Clin Exp Immunol 2011;163:157-64.

Radovits BJ, Kievit W, Fransen J, van de Laar MA, Jansen TL, van Riel PL, et al. Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis. Ann Rheum Dis 2009;68:1470-3.

Strand V, Khanna D. The impact of rheumatoid arthritis and treatment on patients’ lives. Clin Exp Rheumatol 2010;28(3 Suppl 59):32-40.

Cho SK, Kim D, Jun JB, Bae SC, Sung YK. Factors influencing quality of life (QOL) for Korean patients with rheumatoid arthritis (RA). Rheumatol Int 2013;33:93-102.

Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Norton S, et al. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin Arthritis Rheum 2014;44:123-30.

Katchamart W, Narongroeknawin P, Chanapai W, Thaweeratthakul P. Health-related quality of life in patients with rheumatoid arthritis. BMC Rheumatol 2019;3:1-8.

Khanna D, Maranian P, Palta M, Kaplan RM, Hays RD, Cherepanov D, et al. Health-related quality of life in adults reporting arthritis: analysis from the National Health Measurement Study. Qual Life Res 2011;20:1131-40.

Norton S, Fu B, Scott DL, Deighton C, Symmons DP, Wailoo AJ, et al. Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts. Semin Arthritis Rheum 2014;44:131-44.

Tan TC, Gao X, Thong BY, Leong KP, Lian TY, Law WG, et al. Comparison of elderly- and young-onset rheumatoid arthritis in an Asian cohort. Int J Rheum Dis 2017;20:737-45.

Akbulut Aktekin L, Eser F, Sivas F, Keskin D, Ergun Ö, Bodur H. Comparision of disease acitivity and health related quality of life among rheumatoid arthritis patients under and over 60 years. Turkish Journal of Geriatrics 2008;11:181-4.

McPhail SM, Schippers M, Marshall AL. Age, physical inactivity, obesity, health conditions, and health-related quality of life among patients receiving conservative management for musculoskeletal disorders. Clin Interv Aging 2014;9:1069-80.

Vaish K, Patra S, Chhabra P. Functional disability among elderly: A community-based cross-sectional study. J Family Med Prim Care 2020;9:253-8.

Oguro N, Yajima N, Miwa Y. Age and quality of life in patients with rheumatoid arthritis treated with biologic agents. Mod Rheumatol 2020;30:44-9.

Koçyiğit H, Aydemir O, Fişek G, Ölmez N, Memiş A. Reliability and validity of the Turkish version of Short Form-36 (SF-36): Study with a group of patients with rheumatic disease. Journal of Medicine and Treatment 1999;12:102-6.

Günaydın R, Karatepe AG, Demirhan A, Koç A, Kaya T. Impact of fatigue on quality of life in patients with rheumatoid arthritis. Turkiye Klinikleri Med J 2009;29:911-6.

Kalowes P. Symptom Burden at End-of-Life in Patients with Terminal and Life-Threatening Illness in Intensive Care Units. [PhD thesis]. San Diego, USA: University Of San Diego. 2017.

Karaca A. Assessment of effects of different treatment modalities on quality of life in patients with rheumatoid arthritis. [Specialization thesis]. Trabzon, Turkey: Karadeniz Technical University. 2011.

Aslan FE. The Assessment Methods of Pain. Journal of the C. Cumhuriyet Nurs J 2002;6:9-16.

Küçükdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A. Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum 2004;51:14-9.

Walsh DA, McWilliams DF. Mechanisms, impact and management of pain in rheumatoid arthritis. Nat Rev Rheumatol 2014;10:581-92.

Strand V, Wright GC, Bergman MJ, Tambiah J, Taylor PC. Patient Expectations and Perceptions of Goal-setting Strategies for Disease Management in Rheumatoid Arthritis. J Rheumatol 2015;42:2046-54.

Lisitsyna TA, Abramkin AA, Veltishchev DY, Seravina OF, Kovalevskaya OB, Zeltyn AE, et al. Chronic pain and depression in patients with rheumatoid arthritis: Results of five-year follow-up. Ter Arkh 2019;91:8-18.

Simon LS, Taylor PC, Choy EH, Sebba A, Quebe A, Knopp KL, et al. The Jak/STAT pathway: A focus on pain in rheumatoid arthritis. Semin Arthritis Rheum 2021;51:278-84.

Bulut EA, Soysal P, Isik AT. Frequency and coincidence of geriatric syndromes according to age groups: single-center experience in Turkey between 2013 and 2017. Clin Interv Aging 2018;13:1899-905.

Yang YC, Lin MH, Wang CS, Lu FH, Wu JS, Cheng HP, et al. Geriatric syndromes and quality of life in older adults with diabetes. Geriatr Gerontol Int 2019;19:518-24.

Wei MY, Mukamal KJ. Multimorbidity, Mortality, and Long-Term Physical Functioning in 3 Prospective Cohorts of Community-Dwelling Adults. Am J Epidemiol. 2018;187:103-12.

Makovski TT, Schmitz S, Zeegers MP, Stranges S, van den Akker M. Multimorbidity and quality of life: Systematic literature review and meta-analysis. Ageing Res Rev 2019;53:100903.

Berg-Weger M, Morley J. Editorial: Loneliness in Old Age: An unaddressed Health Problem. J Nutr Health Aging 2020;24:243-5.

Liu I, Huang YJ, Wang LK, Tsai YH, Hsu SL, Chang CJ, et al. Dual trajectories of loneliness and depression and their baseline correlates over a 14-year follow-up period in older adults: Results from a nationally representative sample in Taiwan. Int J Older People Nurs 2021;16:e12410.

Vagetti GC, Barbosa Filho VC, Moreira NB, Oliveira Vd, Mazzardo O, Campos Wd, et al. Association between physical activity and quality of life in the elderly: a systematic review, 2000-2012. Braz J Psychiatry 2014;36:76-88.

Seyfzadeh A, Haghighatian M, Mohajerani A. Social Isolation in the Elderly: The Neglected Issue. Iran J Public Health 2019;48:365-6.

Vetrano DL, Foebel AD, Marengoni A, Brandi V, Collamati A, Heckman GA, et al. Chronic diseases and geriatric syndromes: the different weight of comorbidity. Eur J Intern Med 2016;27:62-7.

Evaluation of Quality of Life and Functional Status in Elderly Patients with Rheumatoid Arthritis